Announcement of a new publication

3.10.2022 – We are dedicated to unearth the composition of the rare cell population in health and in disease with the support of SanoLibio technology. Our latest discovery is a …

SanoLibio in Use

24.05.2022 – SanoLibio announces the commencement of a clinical trial conducted by its partner company Premise Biosystems Co., Ltd. (Thailand) in collaboration with Rama Thibodi Hospital in Bangkok for the …

Patent Application – Bone Marrow Damage

20.03.2020 As part of the immanent advancement of cell-based liquid biopsy, we are happy to announce the filing of the latest patent application of the SanoLibio Project introducing the discovery …